Left main coronary artery disease in 2011: CABG or PCI?

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology

Background:

• Left main coronary artery (LMCA) disease affects 5-9% of angina patients, carrying significant mortality risk with medical management.
• Coronary artery bypass grafting (CABG) has been the traditional treatment for unprotected left main coronary artery (ULMCA) disease.
• The proximal location and large caliber of the LMCA present technical challenges for interventional cardiologists.

Purpose of the Study:

• To evaluate percutaneous coronary intervention (PCI) as an alternative to CABG for ULMCA disease.
• To assess the feasibility and outcomes of PCI in patients with ULMCA stenosis.

Main Methods:

• Review of registry reports and a substudy from a large randomized trial comparing PCI and CABG for ULMCA disease.
• Analysis of clinical guidelines regarding treatment options for ULMCA disease.

Main Results:

• Recent guidelines suggest elective PCI can be considered for ULMCA disease, though evidence often favors CABG.
• Registry data and trial substudies indicate PCI may be an acceptable alternative to CABG in specific ULMCA stenosis cases.
• PCI offers short-term benefits including less invasiveness, shorter hospitalization, and quicker recovery compared to CABG.

Conclusions:

• PCI is a potentially acceptable alternative to CABG for select patients with unprotected left main coronary artery disease.
• PCI provides immediate advantages over CABG, including reduced invasiveness and shorter recovery times.
• Patients undergoing PCI for ULMCA disease retain the option for subsequent CABG if needed.